Logo FUNDABETS
Home
Candlestick Pattern Screener Chart Pattern Screener Custom Screener
Contact Us
Sign In Sign Up
Home Candlestick Pattern Screener Chart Pattern Screener Custom Screener Contact Us
Sign In Sign Up

Global Stocks Search

Help with searching

Search our entire platform for stocks by symbol, name, or exchange.

Navidea Biopharmaceuticals, Inc. (NAVB)

USD 0.0

(16.67%)

Overview Income Statements Balance Sheets Cash Flows Historical Prices Other

Inventory Summary of Navidea Biopharmaceuticals, Inc.

  • Navidea Biopharmaceuticals, Inc.'s latest annual inventory in 2022 was 427.34 Thousand USD , up 182.72% from previous year.
  • Navidea Biopharmaceuticals, Inc.'s latest quarterly inventory in 2023 Q3 was 460.74 Thousand USD , down 0.0% from previous quarter.
  • Navidea Biopharmaceuticals, Inc. reported annual inventory of 151.15 Thousand USD in 2021, down -10.98% from previous year.
  • Navidea Biopharmaceuticals, Inc. reported annual inventory of 169.79 Thousand USD in 2020, up 118.84% from previous year.
  • Navidea Biopharmaceuticals, Inc. reported quarterly inventory of 460.63 Thousand USD for 2023 Q1, up 7.79% from previous quarter.
  • Navidea Biopharmaceuticals, Inc. reported quarterly inventory of 460.74 Thousand USD for 2023 Q2, up 0.02% from previous quarter.

Annual Inventory Chart of Navidea Biopharmaceuticals, Inc. (2022 - 1992)

Historical Annual Inventory of Navidea Biopharmaceuticals, Inc. (2022 - 1992)

Year Inventory Inventory Growth
2022 427.34 Thousand USD 182.72%
2021 151.15 Thousand USD -10.98%
2020 169.79 Thousand USD 118.84%
2019 -901.33 Thousand USD -90134000.0%
2018 1.00 USD 0.0%
2017 - USD -100.0%
2016 1.47 Million USD 125.27%
2015 652.9 Thousand USD -29.97%
2014 932.38 Thousand USD -58.23%
2013 2.23 Million USD 650.4%
2012 297.5 Thousand USD -63.79%
2011 821.54 Thousand USD -43.68%
2010 1.45 Million USD 27.53%
2009 1.14 Million USD 18.9%
2008 961.86 Thousand USD -22.27%
2007 1.23 Million USD 7.19%
2006 1.15 Million USD 43.63%
2005 803.7 Thousand USD -6.0%
2004 855.02 Thousand USD -15.2%
2003 1 Million USD -15.4%
2002 1.19 Million USD -16.7%
2001 1.43 Million USD 52.04%
2000 941.12 Thousand USD -17.04%
1999 1.13 Million USD -28.15%
1998 1.57 Million USD 282.28%
1997 413.02 Thousand USD 90.97%
1996 216.27 Thousand USD -56.75%
1995 500 Thousand USD 0.0%
1994 500 Thousand USD -28.57%
1993 700 Thousand USD 250.0%
1992 200 Thousand USD 0.0%
Year Inventory Inventory Growth
2023 Q3 460.74 Thousand USD 0.0%
2023 Q1 460.63 Thousand USD 7.79%
2023 Q2 460.74 Thousand USD 0.02%
2022 Q3 193.8 Thousand USD -38.6%
2022 Q2 315.67 Thousand USD -2.27%
2022 Q1 322.99 Thousand USD 113.68%
2022 FY 427.34 Thousand USD 182.72%
2022 Q4 427.34 Thousand USD 120.5%
2021 Q1 166.24 Thousand USD -2.09%
2021 Q2 178.83 Thousand USD 7.57%
2021 Q3 178.93 Thousand USD 0.06%
2021 Q4 151.15 Thousand USD -15.53%
2021 FY 151.15 Thousand USD -10.98%
2020 Q1 -1.69 Million USD -88.1%
2020 Q3 -820.21 Thousand USD 0.0%
2020 FY 169.79 Thousand USD 118.84%
2020 Q4 169.79 Thousand USD 120.7%
2020 Q2 - USD 100.0%
2019 Q3 -145.81 Thousand USD 29.51%
2019 Q1 1.00 USD 0.0%
2019 Q2 -206.86 Thousand USD -20686400.0%
2019 FY -901.33 Thousand USD -90134000.0%
2019 Q4 -901.33 Thousand USD -518.13%
2018 Q4 1.00 USD 0.0%
2018 FY 1.00 USD 0.0%
2018 Q1 - USD 0.0%
2018 Q2 - USD 0.0%
2018 Q3 1.00 USD 0.0%
2017 Q2 1.00 USD -99.87%
2017 Q1 748.00 USD -99.95%
2017 Q4 - USD 0.0%
2017 Q3 - USD -100.0%
2017 FY - USD -100.0%
2016 Q2 769.82 Thousand USD -14.36%
2016 Q1 898.93 Thousand USD 37.68%
2016 Q4 1.47 Million USD 82.74%
2016 Q3 804.88 Thousand USD 4.55%
2016 FY 1.47 Million USD 125.27%
2015 Q4 652.9 Thousand USD -25.57%
2015 Q1 571.6 Thousand USD -38.69%
2015 FY 652.9 Thousand USD -29.97%
2015 Q2 1.19 Million USD 109.08%
2015 Q3 877.18 Thousand USD -26.6%
2014 Q1 2.11 Million USD -5.31%
2014 FY 932.38 Thousand USD -58.23%
2014 Q2 1.9 Million USD -9.85%
2014 Q4 932.38 Thousand USD -16.77%
2014 Q3 1.12 Million USD -41.22%
2013 Q2 1.32 Million USD 53.33%
2013 Q3 2.04 Million USD 53.62%
2013 FY 2.23 Million USD 650.4%
2013 Q4 2.23 Million USD 9.28%
2013 Q1 867.26 Thousand USD 191.52%
2012 Q3 641 Thousand USD -30.21%
2012 Q1 918.5 Thousand USD 11.8%
2012 Q4 297.5 Thousand USD -53.59%
2012 FY 297.5 Thousand USD -63.79%
2012 Q2 918.5 Thousand USD 0.0%
2011 Q2 1.64 Million USD 10.02%
2011 Q4 821.54 Thousand USD -2.68%
2011 FY 821.54 Thousand USD -43.68%
2011 Q1 1.49 Million USD 2.33%
2011 Q3 844.2 Thousand USD -48.59%
2010 Q1 1.36 Million USD 19.04%
2010 FY 1.45 Million USD 27.53%
2010 Q4 1.45 Million USD -26.14%
2010 Q3 1.97 Million USD 48.84%
2010 Q2 1.32 Million USD -2.54%
2009 FY 1.14 Million USD 18.9%
2009 Q1 976.13 Thousand USD 1.48%
2009 Q4 1.14 Million USD 10.14%
2009 Q3 1.03 Million USD -6.57%
2009 Q2 1.11 Million USD 13.86%
2008 Q1 1.08 Million USD -12.42%
2008 Q4 961.86 Thousand USD 22.35%
2008 Q2 1.04 Million USD -3.24%
2008 FY 961.86 Thousand USD -22.27%
2008 Q3 786.14 Thousand USD -25.03%
2007 Q4 1.23 Million USD 20.73%
2007 FY 1.23 Million USD 7.19%
2007 Q1 1.04 Million USD -9.27%
2007 Q2 1.13 Million USD 8.74%
2007 Q3 1.02 Million USD -10.0%
2006 Q2 812.58 Thousand USD 1.46%
2006 Q1 800.91 Thousand USD -0.35%
2006 FY 1.15 Million USD 43.63%
2006 Q4 1.15 Million USD 10.37%
2006 Q3 1.04 Million USD 28.71%
2005 Q2 756.9 Thousand USD -12.0%
2005 Q4 803.7 Thousand USD -1.71%
2005 FY 803.7 Thousand USD -6.0%
2005 Q1 860.08 Thousand USD 0.59%
2005 Q3 817.72 Thousand USD 8.03%
2004 Q3 946.66 Thousand USD -5.19%
2004 FY 855.02 Thousand USD -15.2%
2004 Q1 921.45 Thousand USD -8.62%
2004 Q2 998.51 Thousand USD 8.36%
2004 Q4 855.02 Thousand USD -9.68%
2003 FY 1 Million USD -15.4%
2003 Q4 1 Million USD -13.6%
2003 Q3 1.16 Million USD 22.44%
2003 Q2 953.09 Thousand USD -1.71%
2003 Q1 969.69 Thousand USD -18.64%
2002 Q4 1.19 Million USD -6.08%
2002 Q1 1.32 Million USD -7.51%
2002 Q2 1.52 Million USD 15.47%
2002 Q3 1.26 Million USD -16.95%
2002 FY 1.19 Million USD -16.7%
2001 Q4 1.43 Million USD -13.35%
2001 Q1 1.3 Million USD 38.43%
2001 FY 1.43 Million USD 52.04%
2001 Q2 1.09 Million USD -15.81%
2001 Q3 1.65 Million USD 50.56%
2000 Q3 453.32 Thousand USD 36.58%
2000 Q1 488.66 Thousand USD -56.76%
2000 FY 941.12 Thousand USD -17.04%
2000 Q4 941.12 Thousand USD 107.61%
2000 Q2 331.89 Thousand USD -32.08%
1999 Q1 1.5 Million USD -5.0%
1999 Q3 1.94 Million USD 29.33%
1999 Q4 1.13 Million USD -41.75%
1999 FY 1.13 Million USD -28.15%
1999 Q2 1.5 Million USD 0.0%
1998 Q2 1 Million USD -16.67%
1998 FY 1.57 Million USD 282.28%
1998 Q4 1.57 Million USD 97.36%
1998 Q1 1.2 Million USD 190.54%
1998 Q3 800 Thousand USD -20.0%
1997 Q2 600 Thousand USD 0.0%
1997 Q3 300 Thousand USD -50.0%
1997 Q4 413.02 Thousand USD 37.67%
1997 Q1 600 Thousand USD 177.43%
1997 FY 413.02 Thousand USD 90.97%
1996 Q4 216.27 Thousand USD -63.95%
1996 Q1 400 Thousand USD -20.0%
1996 Q2 300 Thousand USD -25.0%
1996 Q3 600 Thousand USD 100.0%
1996 FY 216.27 Thousand USD -56.75%
1995 Q2 400 Thousand USD -20.0%
1995 Q4 500 Thousand USD 0.0%
1995 Q1 500 Thousand USD 0.0%
1995 FY 500 Thousand USD 0.0%
1995 Q3 500 Thousand USD 25.0%
1994 FY 500 Thousand USD -28.57%
1994 Q3 700 Thousand USD 0.0%
1994 Q4 500 Thousand USD -28.57%
1994 Q2 700 Thousand USD 0.0%
1994 Q1 700 Thousand USD 0.0%
1993 Q4 700 Thousand USD 133.33%
1993 FY 700 Thousand USD 250.0%
1993 Q1 400 Thousand USD 100.0%
1993 Q2 300 Thousand USD -25.0%
1993 Q3 300 Thousand USD 0.0%
1992 FY 200 Thousand USD 0.0%
1992 Q3 200 Thousand USD 0.0%
1992 Q4 200 Thousand USD 0.0%

Peer Inventory Comparison of Navidea Biopharmaceuticals, Inc.

Name Inventory Inventory Difference
America Great Health 108.35 Thousand USD -294.407%
Ampio Pharmaceuticals, Inc. 1.00 USD -42734300.0%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. - USD -Infinity%
Bio-Path Holdings, Inc. 632.00 USD -67517.722%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 2.5 Million USD 82.969%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. - USD -Infinity%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 34 Thousand USD -1156.894%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 9.97 Million USD 95.716%
Statera Biopharma, Inc. 1.8 Million USD 76.355%
TRACON Pharmaceuticals, Inc. - USD -Infinity%
Trevena, Inc. - USD -Infinity%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. - USD -Infinity%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%
About
Contact
FAQs